xyrem to xywav conversion — what actually works
Company: Jazz Pharmaceuticals
Tags: field, strategy, launch
18 months trying. heres the truth: only focus on new starts. stable xyrem patients dont move and fighting them costs more than its worth. formulary transition argument doesnt land either. payers in my region havent moved. home office playbook doesnt account for any of this
12 upvotes · 6 comments